Topiramate for cocaine dependence during methadone maintenance treatment: A randomized controlled trial

Drug and Alcohol Dependence

Volumn 140, Issue , 2014, Pages 92-100

  Umbricht, Annie ^a   DeFulio, Anthony ^a   Winstanley, Erin L ^a   Tompkins, D Andrew ^a   Peirce, Jessica ^a   Mintzer, Miriam Z ^a   Strain, Eric C ^a   Bigelow, George E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic; Cocaine dependence; Contingency Management; GABA; Glutamate; Topiramate

Indexed keywords

COCAINE; METHADONE; PLACEBO; TOPIRAMATE; FRUCTOSE; NARCOTIC AGENT; NEUROPROTECTIVE AGENT;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG USE; DRUG WITHDRAWAL; ECG ABNORMALITY; EVENING DOSAGE; FEMALE; HEMATURIA; HUMAN; LONG QT SYNDROME; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MORNING DOSAGE; OUTCOME ASSESSMENT; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SUICIDAL IDEATION; URINALYSIS; ADOLESCENT; ANALOGS AND DERIVATIVES; COCAINE-RELATED DISORDERS; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; PATIENT COMPLIANCE; PROCEDURES; SUBSTANCE ABUSE; TREATMENT OUTCOME; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; NEUROPROTECTIVE AGENTS; OPIATE SUBSTITUTION TREATMENT; PATIENT COMPLIANCE; SUBSTANCE ABUSE DETECTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84924842977     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.03.033     Document Type: Article

References (51)

1. Alves O.L., Doyle A.J., Clausen T., Gilman C., Bullock R. Evaluation of topiramate neuroprotective effect in severe TBI using microdialysis. Ann. N.Y. Acad. Sci. 2003, 993:25-34.
2. Anthenelli R.M., Blom T.J., McElroy S.L., Keck P.E. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation. Addiction 2008, 103:687-694.
3. Bäcktröm P., Hyytiä P. Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology 2006, 31:778-786.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
5. Baltieri D.A., Daro F.R., Ribeiro P.L., de Andrade A.G. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 2008, 103:2035-2044.
6. Barrett A.C., Negus S.S., Mello N.K., Caine S.B. Effect of GABA agonists and GABA-A receptor modulators on cocaine and food-maintained responding and cocaine discrimination in rats. J. Pharmacol. Exp. Ther. 2005, 315:858-871.
7. Berlant J.L. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. BMC Psychiatry 2004, 4:24.
8. Braga M.F., Aroniadou-Anderjaska V., Li H., Rogawski M.A. Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. J. Pharmacol. Exp. Ther. 2009, 330:558-566.
9. Brodie J.D., Case B.G., Figueroa E., Dewey S.L., Robinson J.A., Wanderling J.A., Laska E.M. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees. Am. J. Psychiatry 2009, 166:1269-1277.
10. Castells X., Kosten T.R., Capella D., Vidal X., Colom J., Casas M. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: a systematic review and meta-analysis of controlled clinical trials. Am. J. Drug Alcohol Abuse 2009, 35:339-349.
11. Coffey S.F., Dansky B.S., Falsetti S.A., Saladin M.E., Brady K.T. Screening for PTSD in a substance abuse sample: psycho-metric properties of a modified version of the PTSD symptom scale self-report. J. Trauma Stress 1998, 11:393-399.
12. Cornish J.L., Kalivas P.W. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J. Neurosci. 2000, 20:RC89.
13. Elkashef A., Kahn R., Yu E., Iturriaga E., Li S.H., Anderson A., Chiang N., Ait-Daoud N., Weiss D., McSherry F., Serpi T., Rawson R., Hrymoc M., Weis D., McCann M., Pham T., Stock C., Dickinson R., Campbell J., Gorodetzky C., Haning W., Carlton B., Mawhinney J., Li M.D., Johnson B.A. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. Addiction 2012, 107:1297-1306.
14. Gonzales G., Desai R., Sofuoglu M., Poling J., Oliveto A., Gosai K., Kosten T.R. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 2007, 87:1-9.
15. Johnson B.A., Ait-Daoud N., Bowden C.L., DiClemente C.C., Roache J.D., Lawson K., Javors M.A., Ma J.Z. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003, 17:1677-1685.
16. Johnson B.A., Ait-Daoud N., Akhtar F.Z., Ma J.Z. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch. Gen. Psychiatry 2004, 61:905-912.
17. Johnson B.A. Recent advances in the development of treatments for alcohol and cocaine dependence. Focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 2005, 19:873-896.
18. Johnson B.A., Ait-Daoud N., Wang X.Q., Penberthy J.K., Javors M.A., Seneviratne C., Liu L. Topiramate for the treatment of cocaine addiction: a randomized clinical trial. JAMA Psychiatry 2013, 70:1338-1346.
19. Kalivas P.W. Glutamate systems in cocaine addiction. Curr. Opin. Pharmacol. 2004, 4:23-29.
20. Kalivas P.W., LaLumiere R.T., Knackstedt L., Shen H. Glutamate transmission in addiction. Neuropharmacology 2009, 56(Suppl. 1):169-173.
21. Kalivas P.W. The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 2009, 10:561-572.
22. Kampman K.M., Pettinati H., Lynch K.G., Dackis C., Sparkman T., Weigley C., O'Brien C.P. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 2004, 75:233-240.
23. Kampman K.M., Volpicelli J.R., McGinnis D.E., Alterman A.I., Weinrieb R.M., D'Angelo L., Epperson L.E. Reliability and validity of the cocaine selective severity assessment. Addict. Behav. 1998, 23:449-461.
24. Kampman K.M., Pettinati H.M., Lynch K.G., Spratt K., Wierzbicki M.R., O'Brien C.P. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend. 2013, 133:94-99.
25. Khan S., Liberzon I. Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychopharmacology (Berl.) 2004, 172:225-229.
26. Khoromi S., Patsalides A., Parada S., Salehi V., Meegan J.M., Max M.B. Topiramate in chronic lumbar radicular pain. J. Pain 2005, 6:829-836.
27. Kosten T., Oliveto A., Feingold A., Poling J., Sevarino K., McCance-Katz E., Stine S., Gonzalez G., Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend. 2003, 70:315-325.
28. Kubany E.S., Haynes S.N., Leisen M.B., Owens J.A., Kaplan A.S., Watson S.B., Burns K. Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the traumatic life events questionnaire. Psychol. Assess. 2000, 12:210-224.
29. Kupchik Y.M., Scofield M.D., Rice K.C., Cheng K., Roques B.P., Kalivas P.W. Cocaine dysregulates opioid gating of GABA neurotransmission in the ventral pallidum. J. Neursci. 2014, 34:1057-1066.
30. LaRoche S.M., Helmers S.L. The new antiepileptic drugs. JAMA 2004, 291:605-614.
31. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
32. McFarland K., Lapish C.C., Kalivas P.W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug seeking behavior. J. Neurosci. 2003, 23:3531-3537.
33. Moran M.M., McFarland K., Melendez R.I., Kalivas P.W., Seamans J.K. Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J. Neurosci. 2005, 25:6389-6393.
34. Mulvaney F.D., Alterman A.I., Boardman C.R., Kampman K. Cocaine abstinence symptomatology and treatment attrition. J. Subst. Abuse Treat. 1999, 16:129-135.
35. Nickel M.K., Nickel C., Mitterlehner F.O., Tritt K., Lahmann C., Leiberich P.K., Rother W.K., Loew T.H. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J. Clin. Psychiatry 2004, 65:1515-1519.
36. Nickel M.K., Nickel C., Kaplan P., Lahmann C., Muhlbacher M., Tritt K., Krawczyk J., Leiberich P.K., Rother W.K., Loew T.H. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol. Psychiatry 2005, 57:495-499.
37. Nickel C., Lahmann C., Tritt K., Muehlbacher M., Kaplan P., Kettler C., Krawczyk J., Loew T.H., Rother W.K., Nickel M.K. Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study. J. Affect. Disord. 2005, 87:243-252.
38. Peters J., LaLumiere R.T., Kalivas P.W. Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats. J. Neurosci. 2008, 28:6046-6053.
39. Placenza F.M., Rajabi H., Stewart J. Effects of chronic buprenorphine treatment on levels of nucleus accumbens glutamate and on the expression of cocaine-induced behavioral sensitization in rats. Psychopharmacology 2008, 200:347-355.
40. Poling J., Oliveto A., Petry N., Sofuoglu M., Gonsai K., Gonzalez G., Martell B., Kosten T.R. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch. Gen. Psychiatry 2006, 63:219-228.
41. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101:1546-1560.
42. Roll J.M., Reilly M.P., Johanson C.E. The influence of exchange delays on cigarette versus money choice: a laboratory analog of voucher-based reinforcement therapy. Exp. Clin. Psychopharmacol. 2000, 8:366-370.
43. Rubio G., Martinez-Gras I., Manzanares J. Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence. J. Clin. Psychopharmacol. 2009, 29:584-589.
44. Silverman K., Chutuape M.A., Bigelow G.E., Stitzer M.L. Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program. Drug Alcohol Depend. 1996, 41:197-207.
45. Silverman K., Higgins S.T., Brooner R.K., Montoya I.D., Cone E.J., Schuster C.R., Preston K.L. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch. Gen. Psychiatry 1996, 53:409-415.
46. Somoza E.C., Winship D., Gorodetzky C.W., Lewis D., Ciraulo D.A., Galloway G.P., Segal S.D., Sheehan M., Roache J.D., Bickel W.K., Jasinski D., Watson D.W., Miller S.R., Somoza P., Winhusen T. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence. JAMA 2013, 70:630-637.
47. Spielberger C.D. State-Trait Inventory for Adults 1983, Mind Garden, Redwood City, VA.
48. Van Ameringen M., Mancini C., Patterson B., Bennett M. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series. Depress. Anxiety 2006, 23:1-5.
49. Vocci F., Ling W. Medications development: successes and challenges. Pharmacol. Ther. 2005, 108:94-108.
50. Weerts E.M., Froestl W., Griffiths R.R. Effects of GABAergic modulators on food and cocaine self-administration in baboons. Drug Alcohol Depend. 2005, 80. 369-337.
51. Zeger S., Liang K.-Y. An overview of methods for the analysis of longitudinal data. Stats. Med. 1992, 11:1825-1839.